This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the official electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal Register documents. Each document posted on the site includes a link to the corresponding official PDF file on govinfo.gov. This prototype edition of the daily Federal Register on FederalRegister.gov will remain an unofficial informational resource until the Administrative Committee of the Federal Register (ACFR) issues a regulation granting it official legal status. For complete information about, and access to, our official publications and services, go to About the Federal Register on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable regulatory information on FederalRegister.gov with the objective of establishing the XML-based Federal Register as an ACFR-sanctioned publication in the future. While every effort has been made to ensure that the material on FederalRegister.gov is accurately displayed, consistent with the official SGML-based PDF version on govinfo.gov, those relying on it for legal research should verify their results against an official edition of the Federal Register. Until the ACFR grants it official status, the XML rendition of the daily Federal Register on FederalRegister.gov does not provide legal notice to the public or judicial notice to the courts.
Food and Drug Administration, HHS.
Notification of public hearing; request for comments; correction.
The Food and Drug Administration (FDA) is correcting a notice entitled “Standards for Future Opioid Analgesic Approvals and Incentives for New Therapeutics To Treat Pain and Addiction; Public Hearing” that appeared in the Federal Register of June 21, 2019. The document was published with incorrect presenter registration and slide deck submission deadlines. This document corrects those deadlines.
Nicole Zelenak, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 6429, Silver Spring, MD 20993-0002, 301-796-9030.
In the Federal Register of Friday, June 21, 2019 (84 FR 29112), in FR Doc. 2019-13219, on page 29114, the following correction is made:
On page 29114, in the first column, in the “Presenter” bulleted paragraph, the fourth and fifth sentences “Presenters must register no later than August 9, 2019. Slide decks are due to CDER-PublicMeeting@fda.hh.gov in PDF or PowerPoint format no later than August 23, 2019.” are corrected to read “Presenters must register no later than September 6, 2019. Slide decks are due to CDER-PublicMeeting@fda.hh.gov in PDF or PowerPoint format no later than September 6, 2019.”
Dated: August 16, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-18090 Filed 8-21-19; 8:45 am]
BILLING CODE 4164-01-P